Log In
BCIQ
Print this Print this
 

SR-Leuprolide 3 months

  Manage Alerts
Collapse Summary General Information
Company Peptron Inc.
Description3-month injectable formulation of leuprolide
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
PartnerDaewoong Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today